These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7482831

  • 1. Triple therapy with cyclosporine A in kidney transplant patients.
    Matl I, Jirka J, Petrásek R, Vítko S.
    Transplant Proc; 1995 Oct; 27(5):2573. PubMed ID: 7482831
    [No Abstract] [Full Text] [Related]

  • 2. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D, Bardideh A, Samadzadeh B, Razi A.
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract] [Full Text] [Related]

  • 3. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU, Rahman M, Wahab MA, Kibria G, Rahman S, Jinnat S.
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract] [Full Text] [Related]

  • 4. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
    MacDonell RC, Van Buren DH, Richie RE, Johnson HK, Nylander WA, Helderman JH, Ynares CM, Trusler LA, Green WF, Crowe DA.
    Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774
    [No Abstract] [Full Text] [Related]

  • 5. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 6. Rapamycin in a porcine renal transplant model.
    Almond PS, Moss A, Nakhleh R, Melin M, Chen S, Salazar A, Shirabe K, Matas A.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract] [Full Text] [Related]

  • 7. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T, Kapischke M, Busing M.
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M, Demirağ A, Bilgin N, Arslan G, Büyükpamukçu N.
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract] [Full Text] [Related]

  • 9. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
    Løkkegaard H, Asmundsson P, Clausen P, Dieperink H, Hansen JM, Heaf J, Jensen SB, Kornerup HJ, Madsen S, Pedersen EB, Poulsen JV, Rasmussen K.
    Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
    [No Abstract] [Full Text] [Related]

  • 10. Incidence and impact of acute rejection episodes on short- and long-term graft survival in recipients of simultaneous pancreas-kidney transplantation.
    Cantarovich D, Giral M, Josien R, Karam G, Hourmant M, Dantal J, Blancho G, Soulillou JP.
    Transplant Proc; 1995 Feb; 27(1):1319. PubMed ID: 7878897
    [No Abstract] [Full Text] [Related]

  • 11. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
    Bruce DS, Newell KA, Woodle ES, Millis JM, Piper JB, Huss E, Thistlethwaite JR.
    Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
    [No Abstract] [Full Text] [Related]

  • 12. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
    Opelz G.
    Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
    [Abstract] [Full Text] [Related]

  • 13. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P, Baron C, Fruchaud G, Hemery F, Desvaux D, Buisson C, Chopin D, Dahmane D, Remy P, Pastural M, Abbou C, Weil B, Lang P.
    Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
    [Abstract] [Full Text] [Related]

  • 14. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
    Scott-Douglas N, Zimmerman D, Klassen J.
    Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
    [No Abstract] [Full Text] [Related]

  • 15. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
    Ghoneim MA, Sobh MA, Shokeir AA, Bakr MA, el-Sherif A, Foda MA.
    Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
    [No Abstract] [Full Text] [Related]

  • 16. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 17. Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation.
    Heroux AL, LeBlanc MH, Beaudoin D, Simard S, Coulombe DA, Gleeton O, Lemieux MD, Doyle DP.
    Transplant Proc; 1996 Dec; 28(6):3145-8. PubMed ID: 8962219
    [No Abstract] [Full Text] [Related]

  • 18. High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
    Sakhuja V, Sharma UK, Jha V, Minz M, Chugh KS.
    Transplant Proc; 1995 Oct; 27(5):2728-30. PubMed ID: 7482892
    [No Abstract] [Full Text] [Related]

  • 19. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO, Wheatley T, Feehally J, Nicholson ML, Veitch PS, Bell PR.
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract] [Full Text] [Related]

  • 20. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
    Jazzar A, Fagiuoli S, Sisson S, Zuhdi N, Cooper DK.
    Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.